Anka C. Röhr

588 total citations
22 papers, 280 citations indexed

About

Anka C. Röhr is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Anka C. Röhr has authored 22 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 12 papers in Epidemiology and 6 papers in Molecular Medicine. Recurrent topics in Anka C. Röhr's work include Antibiotics Pharmacokinetics and Efficacy (18 papers), Sepsis Diagnosis and Treatment (7 papers) and Antibiotic Resistance in Bacteria (6 papers). Anka C. Röhr is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (18 papers), Sepsis Diagnosis and Treatment (7 papers) and Antibiotic Resistance in Bacteria (6 papers). Anka C. Röhr collaborates with scholars based in Germany, Australia and France. Anka C. Röhr's co-authors include Otto Frey, Alexander Brinkmann, Jason A. Roberts, Christina König, Stefan Kluge, Dominic Wichmann, Daniel Richter, Thomas Fuchs, Markus Weigand and Thorsten Brenner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Anka C. Röhr

21 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anka C. Röhr Germany 10 205 121 72 57 47 22 280
Athena L V Hobbs United States 10 121 0.6× 129 1.1× 65 0.9× 68 1.2× 47 1.0× 31 355
Saiping Jiang China 6 143 0.7× 88 0.7× 73 1.0× 43 0.8× 18 0.4× 10 247
Sofie Dhaese Belgium 11 214 1.0× 155 1.3× 90 1.3× 85 1.5× 29 0.6× 19 299
Fabio Taccone Belgium 10 242 1.2× 178 1.5× 69 1.0× 58 1.0× 53 1.1× 24 386
Marco R. Scipione United States 11 114 0.6× 106 0.9× 99 1.4× 41 0.7× 34 0.7× 23 313
D. Matthew Shoemaker United States 5 176 0.9× 86 0.7× 61 0.8× 41 0.7× 32 0.7× 10 301
E. Papy France 9 116 0.6× 95 0.8× 89 1.2× 97 1.7× 52 1.1× 15 320
Christian Lanckohr Germany 12 104 0.5× 104 0.9× 53 0.7× 69 1.2× 65 1.4× 29 347
Abderrahim Karmime Switzerland 6 281 1.4× 176 1.5× 76 1.1× 72 1.3× 31 0.7× 8 442
Tim M. J. Ewoldt Netherlands 9 309 1.5× 174 1.4× 90 1.3× 112 2.0× 62 1.3× 20 355

Countries citing papers authored by Anka C. Röhr

Since Specialization
Citations

This map shows the geographic impact of Anka C. Röhr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anka C. Röhr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anka C. Röhr more than expected).

Fields of papers citing papers by Anka C. Röhr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anka C. Röhr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anka C. Röhr. The network helps show where Anka C. Röhr may publish in the future.

Co-authorship network of co-authors of Anka C. Röhr

This figure shows the co-authorship network connecting the top 25 collaborators of Anka C. Röhr. A scholar is included among the top collaborators of Anka C. Röhr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anka C. Röhr. Anka C. Röhr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jarczak, Dominik, Christina König, Anka C. Röhr, et al.. (2025). Potential drug interactions with nirmatrelvir/ritonavir in critically ill patients with COVID-19: a retrospective observational study. 4(1). 1 indexed citations
2.
Groote, Thilo von, et al.. (2024). No Sequestration of Commonly Used Anti-Infectives in the Extracorporeal Membrane Oxygenation (ECMO) Circuit—An Ex Vivo Study. Antibiotics. 13(4). 373–373. 4 indexed citations
3.
Richter, Daniel, Otto Frey, Anka C. Röhr, et al.. (2023). Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients. Antibiotics. 12(7). 1112–1112. 4 indexed citations
4.
Brinkmann, Alexander, Anka C. Röhr, Otto Frey, et al.. (2023). Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. Antimicrobial Agents and Chemotherapy. 67(5). e0010423–e0010423. 9 indexed citations
5.
Dubler, Simon, Thorsten Brenner, Stefan Zimmermann, et al.. (2022). Off-Label Use of Ceftolozane/Tazobactam for the Successful Treatment of Healthcare-Associated Meningitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa in a Polytraumatized Patient—A Case Report. SHILAP Revista de lepidopterología. 5(3). 33–33. 1 indexed citations
6.
Wicha, Sebastian G., Otto Frey, Thomas Fuchs, et al.. (2022). Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients. International Journal of Antimicrobial Agents. 59(5). 106572–106572. 17 indexed citations
7.
8.
9.
Dubinski, Daniel, Florian J. Raimann, Otto Frey, et al.. (2021). Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion. Antibiotics. 10(11). 1421–1421. 8 indexed citations
10.
11.
Röhr, Anka C., et al.. (2021). Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Cefiderocol. Antibiotics. 10(3). 242–242. 13 indexed citations
12.
König, Christina, Anna Both, Holger Rohde, et al.. (2021). Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics. 10(6). 649–649. 17 indexed citations
13.
14.
Brinkmann, Alexander, Anka C. Röhr, Otto Frey, et al.. (2018). S2k-Leitlinie der PEG zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen. Der Anaesthesist. 67(12). 936–949. 13 indexed citations
15.
Brinkmann, Alexander, Anka C. Röhr, Thomas Fuchs, et al.. (2018). Adäquate Antiinfektivatherapie. Der Anaesthesist. 67(6). 461–476. 9 indexed citations
16.
Röhr, Anka C., et al.. (2018). SOP Individuelle Dosierung und Applikation von Antiinfektiva auf der Intensivstation. 14(3). 238–243. 7 indexed citations
17.
König, Christina, Anka C. Röhr, Otto Frey, et al.. (2018). In vitro removal of anti-infective agents by a novel cytokine adsorbent system. The International Journal of Artificial Organs. 42(2). 57–64. 57 indexed citations
18.
Brinkmann, Alexander, Anka C. Röhr, Wolfgang Krüger, & Otto Frey. (2017). Therapeutisches Drug-Monitoring in der antiinfektiven Therapie. 12(1). 59–71. 1 indexed citations
19.
Brinkmann, Alexander, et al.. (2016). Therapeutisches Drug Monitoring und individualisierte Dosierung von Antibiotika bei der Sepsis. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 113(2). 82–93. 17 indexed citations
20.
Röhr, Anka C., et al.. (2008). Pseudotumor cerebri – was ist normal? Normwerte für indirekte marker bei intrakranieller Hypertension. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 180(S 1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Athena L V Hobbs Breakdown of academic impact, for papers by Saiping Jiang Breakdown of academic impact, for papers by Sofie Dhaese Breakdown of academic impact, for papers by Fabio Taccone Breakdown of academic impact, for papers by Marco R. Scipione Breakdown of academic impact, for papers by D. Matthew Shoemaker Breakdown of academic impact, for papers by E. Papy Breakdown of academic impact, for papers by Christian Lanckohr Breakdown of academic impact, for papers by Abderrahim Karmime Breakdown of academic impact, for papers by Tim M. J. Ewoldt
Rankless by CCL
2026